150 related articles for article (PubMed ID: 26912234)
1. Development and evaluation of rapid point-of-care tests for detection of Enterovirus 71 and Coxsackievirus A16 specific immunoglublin M antibodies.
Zhang J; Weng Z; Du H; Xu F; He S; He D; Cheng T; Zhang J; Ge S; Xia N
J Virol Methods; 2016 May; 231():44-7. PubMed ID: 26912234
[TBL] [Abstract][Full Text] [Related]
2. Protein microarray-mediated detection of antienterovirus antibodies in serum.
Zhang A; Xiu B; Zhang H; Li N
J Int Med Res; 2016 Apr; 44(2):287-96. PubMed ID: 26831405
[TBL] [Abstract][Full Text] [Related]
3. Analysis and solution of false-positives when testing CVA16 sera using an antibody assay against the EV71 virus.
Wang C; You A; Tian X; Zhao M; Chen Y; Lin T; Zheng J; Xiao M; Zhang Y; Kuang L; Zhou Z; Zhu B
Virus Res; 2013 Sep; 176(1-2):33-6. PubMed ID: 23707400
[TBL] [Abstract][Full Text] [Related]
4. Relationship between serologic response and clinical symptoms in children with enterovirus 71-infected hand-foot-mouth disease.
Shen J; Zhao C; Cao P; Shi P; Cao L; Zhu Q
Int J Clin Exp Pathol; 2015; 8(9):11608-14. PubMed ID: 26617898
[TBL] [Abstract][Full Text] [Related]
5. [A pathogen analysis within 174 cases of hand-foot-mouth disease in the summer of 2009].
Fu J; Cui XD; Sun CR; Wang TY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):377-80. PubMed ID: 22338230
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of human enterovirus 71 and coxsackievirus A16 specific immunoglobulin M antibodies for diagnosis of hand-foot-and-mouth disease.
Yu N; Guo M; He SJ; Pan YX; Chen XX; Ding XX; Hao W; Wang YD; Ge SX; Xia NS; Che XY
Virol J; 2012 Jan; 9():12. PubMed ID: 22234169
[TBL] [Abstract][Full Text] [Related]
7. Application value of EV/EV71/CA16-SAT detection in children with hand-foot-mouth disease.
Cai J; Lv H; Ding X; Zhao Y; Yu C; Luo Y; Wang Z; He L; Sun Z; Lu Y; Yang L; Chen F; Li X
Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(12):65-71. PubMed ID: 38063116
[TBL] [Abstract][Full Text] [Related]
8. Comparing Enterovirus 71 with Coxsackievirus A16 by analyzing nucleotide sequences and antigenicity of recombinant proteins of VP1s and VP4s.
Li Y; Zhu R; Qian Y; Deng J; Sun Y; Liu L; Wang F; Zhao L
BMC Microbiol; 2011 Nov; 11():246. PubMed ID: 22050722
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand.
Lerdsamran H; Prasertsopon J; Mungaomklang A; Klinmalai C; Noisumdaeng P; Sangsiriwut K; Tassaneetrithep B; Guntapong R; Iamsirithaworn S; Puthavathana P
Virol J; 2018 Oct; 15(1):158. PubMed ID: 30326914
[TBL] [Abstract][Full Text] [Related]
10. Applicability of duplex real time and lateral flow strip reverse-transcription recombinase aided amplification assays for the detection of Enterovirus 71 and Coxsackievirus A16.
Li XN; Shen XX; Li MH; Qi JJ; Wang RH; Duan QX; Zhang RQ; Fan T; Bai XD; Fan GH; Xie Y; Ma XJ
Virol J; 2019 Dec; 16(1):166. PubMed ID: 31888694
[TBL] [Abstract][Full Text] [Related]
11. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
Mao Q; Wang Y; Shao J; Ying Z; Gao F; Yao X; Li C; Ye Q; Xu M; Li R; Zhu F; Liang Z
Hum Vaccin Immunother; 2015; 11(11):2723-33. PubMed ID: 25715318
[TBL] [Abstract][Full Text] [Related]
12. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
[TBL] [Abstract][Full Text] [Related]
13. [Detection of enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Shanghai, 2002].
Yang ZH; Zhu QR; Li XZ; Wang XH; Wang JS; Hu JY; Tang W; Cui AL
Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):648-52. PubMed ID: 16191294
[TBL] [Abstract][Full Text] [Related]
14. Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany.
Rabenau HF; Richter M; Doerr HW
Med Microbiol Immunol; 2010 Feb; 199(1):45-51. PubMed ID: 19941005
[TBL] [Abstract][Full Text] [Related]
15. Development of an IgM-capture ELISA for Coxsackievirus A16 infection.
Xu F; He D; He S; Wu B; Guan L; Niu J; Li L; Li C; Weng Z; Yan Q; Yang L; Ge S; Cheng T; Chen Y; Zhang J; Xia N
J Virol Methods; 2011 Jan; 171(1):107-10. PubMed ID: 20970457
[TBL] [Abstract][Full Text] [Related]
16. Expression of enterovirus 71 capsid protein VP1 in Escherichia coli and its clinical application.
Shi M; Zhou Y; Cao L; Ding C; Ji Y; Jiang Q; Liu X; Li X; Hou X; Peng H; Shi W
Braz J Microbiol; 2013 Dec; 44(4):1215-22. PubMed ID: 24688514
[TBL] [Abstract][Full Text] [Related]
17. Understanding the epidemiological characteristics of EV71 and CVA16 infection to aid the diagnosis and treatment of hand, foot, and mouth disease.
Wang B; Li J; Wang Y; Du N; Sun L; Xiao H; Zhao Y; Bao W; Zhang W
J Med Virol; 2019 Feb; 91(2):201-207. PubMed ID: 30118553
[TBL] [Abstract][Full Text] [Related]
18. Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71.
Zhang C; Yang Y; Chi Y; Yin J; Yan L; Ku Z; Liu Q; Huang Z; Zhou D
Vaccine; 2015 Sep; 33(39):5087-94. PubMed ID: 26296491
[TBL] [Abstract][Full Text] [Related]
19. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses.
Cai Y; Ku Z; Liu Q; Leng Q; Huang Z
Vaccine; 2014 May; 32(21):2406-12. PubMed ID: 24657161
[TBL] [Abstract][Full Text] [Related]
20. [Comparisons of epidemiological and clinical characteristics in children with hand-foot-mouth disease caused by Enterovirus 71 and Coxackievirus A16].
Jia L; Zhao CS; Zhang L; Li S; Zhang DT; Liu BW; Wang QY; Li XY
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Aug; 13(8):635-7. PubMed ID: 21849112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
